Register
First interoperable insulin pump that allows patients to customize treatment through their individual diabetes management devices gets FDA go ahead |
News and Updates
eMediNexus Coverage from: 
First interoperable insulin pump that allows patients to customize treatment through their individual diabetes management devices gets FDA go ahead

0 Read Comments                

The US Food and Drug Administration has permitted marketing of the Tandem Diabetes Care t: Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes. This new type of insulin pump, referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin pump, is the first interoperable pump, meaning it can be used with different components that make up diabetes therapy systems, allowing patients to tailor their diabetes management to their individual device preferences.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now